Amsurg Corp.

0000950144-04-008825.txt : 20040901 0000950144-04-008825.hdr.sgml : 20040901 20040901172702 ACCESSION NUMBER: 0000950144-04-008825 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040901 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20040901 DATE AS OF CHANGE: 20040901 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMSURG CORP CENTRAL INDEX KEY: 0000895930 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 621493316 STATE OF INCORPORATION: TN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-22217 FILM NUMBER: 041011827 BUSINESS ADDRESS: STREET 1: 20 BURTON HILLS BLVD STREET 2: STE 350 CITY: NASHVILLE STATE: TN ZIP: 37215 BUSINESS PHONE: 6156651283 MAIL ADDRESS: STREET 1: ONE BURTON HILLS BLVD. STREET 2: SUITE 350 CITY: NASHVILLE STATE: TN ZIP: 37215 8-K 1 g90830e8vk.htm AMSURG CORP. Amsurg Corp.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 1, 2004 (September 1, 2004)

AMSURG CORP.
(Exact Name of Registrant as Specified in Charter)


Tennessee	000-22217	62-1493316
(State or Other Jurisdiction of	(Commission	(I.R.S. Employer
Incorporation)	File Number)	Identification No.)


20 Burton Hills Boulevard
Nashville, Tennessee		37215
(Address of Principal Executive Offices)		(Zip Code)

(615) 665-1283
(Registrant’s Telephone Number, Including Area Code)

Not Applicable
(Former Name orFormerAddress, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01. Regulation FD Disclosure

A press release issued by AmSurg Corp. on September 1, 2004 is furnished herewith as Exhibit 99.

Item 9.01. Financial Statements and Exhibits

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	AMSURG CORP.

	By:	/s/ Claire M. Gulmi
		Claire M. Gulmi

		Senior Vice President and Chief Financial Officer
		(Principal Financial and Duly Authorized Officer)

Date: September 1, 2004

INDEX TO EXHIBITS


Exhibit
Number		Description

99		Press release dated September 1, 2004

EX-99 2 g90830exv99.htm EX-99 PRESS RELEASE Ex-99 Press Release

Exhibit 99

Press Release

AMSURG CORP. TO PRESENT AT THOMAS WEISEL PARTNERS
HEALTHCARE TAILWINDS 2004 RESEARCH CONFERENCE
_____________

LIVE PRESENTATION AND REPLAY AVAILABLE VIA THE INTERNET
BEGINNING THURSDAY, SEPTEMBER 9TH, AT 10:35 A.M. EASTERN

NASHVILLE, Tenn. (September 1, 2004) – AmSurg Corp. (Nasdaq: AMSG) today announced that it will participate in the Healthcare Tailwinds 2004 research conference to be hosted by Thomas Weisel Partners, September 8th through September 10th in Boston. In connection with the conference, there will be an on-line simulcast and a replay of the Company’s presentation available at the Company’s web site starting at 10:35 a.m. Eastern on Thursday, September 9, 2004. Claire M. Gulmi, Senior Vice President and Chief Financial Officer, will be speaking at the conference.

The live audio Webcast and replay of the presentation will be available by going to www.amsurg.com. Please go to the site at least 15 minutes prior to the presentation to download and install any necessary audio software.

AmSurg Corp. develops, acquires and manages physician practice-based ambulatory surgery centers in partnership with surgical and other group practices. At June 30, 2004, AmSurg owned a majority interest in 117 centers and had 13 centers under development.

Contact:

Claire M. Gulmi
Senior Vice President and
Chief Financial Officer
(615) 665-1283

-END-